|
Thomas L. Lentz, MD, is currently Dean of Admissions at Yale University having taken this position fulltime. Prior to this post he was head of the Department of Cell Biology where he originated the theory that the Rabies virus employed the nicotinic receptor as the entry portal. Dr. Lentz and his groups published extensively on the subject. He has agreed to act as a consultant to ReceptoPharm with the option of joining the Scientific Advisory Board. | 